Pfizer to Ask US Regulators to Authorize COVID Vaccine Booster for Kids in 5–11 Age Group
April 15, 2022 • by Zachary Stieber, The Epoch Times
A child receives a dose of Pfizer’s Covid-19 vaccine at an event launching school vaccinations in Los Angeles, California on November 5, 2021. – The United States can now start giving children aged 5-11 the Pfizer-BioNtech Covid vaccine, US health authorities said Tuesday in a move hailed by President Joe Biden as a “turning point” in the fight against the pandemic. (Photo by Frederic J. BROWN / AFP) (Photo by FREDERIC J. BROWN/AFP via Getty Images)
Pfizer and BioNTech plan on asking the U.S. Food and Drug Administration (FDA) to grant emergency use authorization for a booster for their COVID-19 vaccine for children aged 5- to 11-years-old, the companies announced on April 14.
